Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

By Osako Tomo   Ito Yoshinori   Takahashi Shunji   Tokudome Nahomi   Iwase Takuji   Hatake Kiyohiko  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

By Roché Henri  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 755-765

Springer Publishing Company

Access to resources Recommend Favorite

Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

By Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 186-189

Informa Healthcare

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite